From Financialisation to Innovation in UK Big Pharma

AstraZeneca and GlaxoSmithKline

Description

This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.
€ 24,55
Paperback / softback
 
Free shipping from
€ 19,95 within The Netherlands
Year
2022
Language
English
Pages
116
Weight
188 gr
EAN
9781009278164
Dimensions
152 x 229 x 11 mm
Binding format
Paperback / softback

You will always receive the last edition from us!


Categories

Boekstra